$McKesson(MCK)$
McKesson Corp (MCK) Soared +16.52%: Bullish Momentum Confirmed, Eyeing $1000 Target
Latest Close Data:
MCK closed at $957.80 on Feb 5, 2026, surging +16.52% ($135.80). This places it just 1.5% below its 52-week high of $971.93.
Core Market Drivers:
-
A significant capital inflow of $669 million over the past five days (Feb 4) suggests strong institutional buying.
-
The healthcare distribution sector remains resilient, with MCK benefiting from stable pharmaceutical demand.
Technical Analysis:
-
Volume surged to 2.25M shares (Volume Ratio: 2.50), confirming the breakout.
-
The MACD shows a strong bullish signal with DIF (12.55) crossing above DEA (3.91) and a large positive histogram (17.28).
-
The 6-day RSI is at a high 82.95, indicating strong momentum but nearing overbought territory.
Key Price Levels:
-
Immediate Pivot: $958 (Current consolidation level).
-
Primary Support: $821 (Previous resistance turned support).
-
Strong Resistance: $972 (52-week high).
Valuation Perspective:
TTM P/E is 29.82, which is elevated compared to its historical forward P/E average of ~18.05, but justified by strong earnings growth (EPS TTM: $32.12). P/S ratio of 0.30 remains attractive for the sector.
Analyst Targets:
16 analysts have an average price target of $945.53, with a high of $1000. Sentiment is bullish with 6 Strong Buy, 10 Buy, and 2 Hold ratings.
Weekly Outlook:
Expect consolidation near the $958 pivot. A successful break above $972 resistance could target the $1000 psychological level. Failure to hold $940 may lead to a pullback towards $900 support.
Comments